FXE Stock Chart Mon, Jan 27th, 2014

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
FXE Stock Chart and Technical Analysis - Mon, Jan 27th, 2014 $FXE

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  134.71  +1.47  +1.10%  458,420
20 Day  134.87  -0.23  -0.17%  502,620
50 Day  134.76  +2.25  +1.69%  480,632
100 Day  134.23  +4.72  +3.62%  421,429
200 Day  132.19  +5.29  +4.07%  460,112
Year to Date  134.66  -0.85  -0.63%  532,553

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 85.48% 90.13% 67.83% 0.60
14 Day 85.48% 90.13% 66.86% 0.61
20 Day 51.17% 53.96% 40.39% 0.62
50 Day 64.73% 66.75% 60.13% 0.65
100 Day 77.31% 78.52% 72.66% 0.70

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 55.00% 14.52% 7.72% +0.61
14 Day 52.84% 14.52% 6.63% +0.58
20 Day 52.24% 48.83% 6.94% +0.35
50 Day 52.71% 35.27% 5.72% +0.46
100 Day 52.68% 22.69% 6.24% +1.00

FXE Stock Chart and Technical Analysis - Mon, Jan 27th, 2014
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading